Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | PHA-00767505E | None | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | PHA-00767505E | None | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | PHA-00767505E | None | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | PHA-00767505E | None | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | gemfibrozil | 3463 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | gemfibrozil | 3463 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | gemfibrozil | 3463 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | gemfibrozil | 3463 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | gemfibrozil | 3463 | drug-path |
Nucleotide excision repair | R-HSA-5696398 | map03420 | oxymetazoline | 4636 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | oxymetazoline | 4636 | drug-path |
Gap junction | R-HSA-190861 | map04540 | oxymetazoline | 4636 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | oxymetazoline | 4636 | drug-path |
Gap junction | R-HSA-190861 | map04540 | ethaverine | 135398735 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | ethaverine | 135398735 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | ethaverine | 135398735 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ethaverine | 135398735 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ethaverine | 135398735 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | ethaverine | 135398735 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | glipizide | 3478 | drug-path |